Company Email Format Management

Remedy Plan Therapeutics

Biotechnology Gaithersburg, Maryland, United States 14 employees

Employees: 14
Contacts: 3
Emails: 3
Phones: 2

remedyplan.com LinkedIn Crunchbase

Remedy Plan Therapeutics Overview

Headquarters: Gaithersburg, Maryland, United States
Phone Number: Available in AeroLeads
Website: remedyplan.com
Industry: Biotechnology
Employees: 14
Founded: 2016
Funding: 18.0M
Company Email: Available in AeroLeads

Keywords

Cancer Drug Development Biotechnology Cancer Containment Therapy Cancer Stem Cells NAMPT inhibition

About Remedy Plan Therapeutics

Remedy Plan Therapeutics is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for hyperbolic inhibition of NAMPT that is highly tunable. Remedy’s groundbreaking mechanism of action, which provides NAMPT inhibition without severe on-target toxicity, unlocks opportunities to treat a range of diseases caused by NAMPT dysregulation. We are advancing a robust pipeline of tunable NAMPT inhibitors, to address solid tumors, hematologic malignancies, obesity, and autoimmune disorders. Remedy's lead asset is RPT1G. With a favorable efficacy and tolerability profile, RPT1G will be advancing to the clinic in 2024.

Remedy Plan Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Remedy Plan Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gregory Crimmins	CEO at Remedy Plan	Washington, District of Columbia, United States	Email Phone
Banumathi Cole	Drug Discovery Leader - Preclinical		View
Asra Rehan	Project Management - Mba	Frederick, Maryland, United States	Email
Tom Dubensky	Chief Executive Officer at Immunesensor	Berkeley, California, United States	Email Phone